---  
layout: startup_page  
title: "Amlogenyx"  
id: "amlogenyx.com"  
permalink: "/amlogenyxamlogenyx.com08022024/"  
website: "https://www.amlogenyx.com"  
funding_round: "Seed"  
funding_amount: "$14M"  
investors: "GordonMD ® Global Investments LP, Ultragenyx"  
about: "Amlogenyx Inc., a subsidiary of Ultragenyx Pharmaceutical, Inc., is focused on researching and developing novel gene therapies for Alzheimer's disease and other amyloid diseases. Their lead product candidate is a protease designed to break down Aβ42, a protein believed to be responsible for Alzheimer's debilitating effects."  
markets: "Biotechnology, Gene Therapy, Pharmaceuticals, Genetics, Therapeutics"  
hq: "Somerville, Massachusetts, United States"  
founded_year: "2023"  
linkedin: ""  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/amlogenyx"  
pitchbook: "https://pitchbook.com/profiles/company/620154-64"  

date_display: "02-Aug-2024"  
date: "2024-08-02"

# SEO Optimization  
meta_title: "Amlogenyx - Seed Funding ($14M)"  
meta_description: "Amlogenyx, Amlogenyx Inc., a subsidiary of Ultragenyx Pharmaceutical, Inc., is focused on researching and developing novel gene therapies for Alzheimer's disease..."  
meta_keywords: "Amlogenyx, Biotechnology, Gene Therapy, Pharmaceuticals, Genetics, Therapeutics, Seed funding"  
canonical_url: "https://startup.projectstartups.com/amlogenyxamlogenyx.com08022024/"  
---